Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Retained earnings

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Dec 31, 2025-3,066+35.66%
Dec 31, 2024-2,260-79.38%
Dec 31, 2023-10,961+31.92%
Dec 31, 2022-8,309+57.57%
Dec 31, 2021-5,273+97.83%
Sep 30, 2021-2,666+3036.23%
Sep 30, 2020-85-98.97%
Sep 30, 2019-8,225-606.24%
Sep 30, 20181,625-43.53%
Sep 30, 20172,877+37.58%
Sep 30, 20162,091+47.50%
Sep 30, 20151,418+49.54%
Sep 30, 2014948

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat